GlassScriptPhysician profile
Linh T Ngo
NPI 1417444282
$24,143.30
in general payments reported to CMS, 2019-2025
15 companies · $2,140 in 2025
The $2,140 reported for 2025 was more than what 97% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,001 · 2020: $391 · 2021: $1,617 · 2022: $13K · 2023: $4,147 · 2024: $1,114 · 2025: $2,140.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,639 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $3,500 · Travel and Lodging: $262.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,639.21 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $3,500.00 |
| Travel and Lodging | $262.05 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coopervision INC. | $15,667.78 | 2021-2025 | Misight Contact Lens, Onefit Contact Lens, Ortho-K Contact Lens |
| Johnson & Johnson Vision Care, INC. | $2,888.44 | 2019-2025 | Acuvue |
| Lumenis Be INC | $2,400.03 | 2022-2025 | Optilight, M22 |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $1,187.33 | 2019-2021 | |
| Tarsus Pharmaceuticals, INC. | $559.06 | 2024 | Xdemvy |
| Alcon Vision LLC | $523.75 | 2022 | |
| Sun Pharmaceutical Industries INC. | $297.30 | 2019-2022 | |
| Optos, INC. | $122.21 | 2019 | |
| Lumenis, INC | $114.49 | 2021 | |
| Glaukos Corporation | $95.67 | 2025 | Idosetr |
| Bausch & Lomb Americas INC. | $95.49 | 2024 | Infuse |
| Dompe US, INC. | $68.45 | 2025 | Oxervate |
| Rxsight INC | $62.50 | 2025 | Rxsight Light Delivery Device (Ldd), Rxsight Contact Lens, Light Adjustable Lens (Lal) |
| Johnson & Johnson Surgical Vision, INC. | $35.80 | 2023 | Lipiflow System Activator (Disposable), Meibomian Gland Evaluator |
| Biotissue Holdings INC. | $25.00 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Linh Ngo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.